ALDH5A1 and ovarian carcinoma: Additionally, succinate-semialdehyde dehydrogenase, mitochondrial (ALDH5A1), which is involved in glutamate metabolism, was elevated in post-NACT treated tumors and work by Tian and colleagues identified that low expression of ALDH5A1 is associated with worse overall survival in ovarian cancer [22].